Cargando…
Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer
Head and neck cancer (HNC) ranks as the sixth most prevalent type of cancer globally and accounts for about 4% of all types of cancer. Among all HNC, most are head and neck squamous cell carcinoma (HNSCC) with clinical therapies that include surgery, radiation therapy, chemotherapy, immunotherapy, t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346844/ https://www.ncbi.nlm.nih.gov/pubmed/37457699 http://dx.doi.org/10.3389/fimmu.2023.1213716 |
_version_ | 1785073409390018560 |
---|---|
author | Hu, Chunmei Liu, Min Li, Yutao Zhao, Yi Sharma, Amit Liu, Haotian Schmidt-Wolf, Ingo G. H. |
author_facet | Hu, Chunmei Liu, Min Li, Yutao Zhao, Yi Sharma, Amit Liu, Haotian Schmidt-Wolf, Ingo G. H. |
author_sort | Hu, Chunmei |
collection | PubMed |
description | Head and neck cancer (HNC) ranks as the sixth most prevalent type of cancer globally and accounts for about 4% of all types of cancer. Among all HNC, most are head and neck squamous cell carcinoma (HNSCC) with clinical therapies that include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and multimodal treatments. In recent years, chimeric antigen receptor (CAR)-T cell immunotherapy has significantly transformed the therapeutic approaches for leukemia and lymphoma and has garnered increased attention as a potential treatment for a wide range of cancers. However, CAR-T immunotherapy in solid tumors, especially HNSCCs, lags significantly behind due to the paucity of tumor-specific antigens, high levels of tumor heterogeneity, immunosuppressive tumor microenvironment, the risk of treatment-related toxicities and off-target adverse events in HNSCCs. The objective of this review is to explore the advancement of CAR-T cell therapy in the treatment of HNSCCs. We aim to outline the targeted antigens in HNSCCs, highlight the challenges and potential solutions, and discuss the relevant combination therapies. Our review presents a comprehensive overview of the recent developments in CAR-T cell therapy for HNSCCs, and provides valuable insights into future research avenues. |
format | Online Article Text |
id | pubmed-10346844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103468442023-07-15 Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer Hu, Chunmei Liu, Min Li, Yutao Zhao, Yi Sharma, Amit Liu, Haotian Schmidt-Wolf, Ingo G. H. Front Immunol Immunology Head and neck cancer (HNC) ranks as the sixth most prevalent type of cancer globally and accounts for about 4% of all types of cancer. Among all HNC, most are head and neck squamous cell carcinoma (HNSCC) with clinical therapies that include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and multimodal treatments. In recent years, chimeric antigen receptor (CAR)-T cell immunotherapy has significantly transformed the therapeutic approaches for leukemia and lymphoma and has garnered increased attention as a potential treatment for a wide range of cancers. However, CAR-T immunotherapy in solid tumors, especially HNSCCs, lags significantly behind due to the paucity of tumor-specific antigens, high levels of tumor heterogeneity, immunosuppressive tumor microenvironment, the risk of treatment-related toxicities and off-target adverse events in HNSCCs. The objective of this review is to explore the advancement of CAR-T cell therapy in the treatment of HNSCCs. We aim to outline the targeted antigens in HNSCCs, highlight the challenges and potential solutions, and discuss the relevant combination therapies. Our review presents a comprehensive overview of the recent developments in CAR-T cell therapy for HNSCCs, and provides valuable insights into future research avenues. Frontiers Media S.A. 2023-06-29 /pmc/articles/PMC10346844/ /pubmed/37457699 http://dx.doi.org/10.3389/fimmu.2023.1213716 Text en Copyright © 2023 Hu, Liu, Li, Zhao, Sharma, Liu and Schmidt-Wolf https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Hu, Chunmei Liu, Min Li, Yutao Zhao, Yi Sharma, Amit Liu, Haotian Schmidt-Wolf, Ingo G. H. Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer |
title | Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer |
title_full | Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer |
title_fullStr | Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer |
title_full_unstemmed | Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer |
title_short | Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer |
title_sort | recent advances and future perspectives of car-t cell therapy in head and neck cancer |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346844/ https://www.ncbi.nlm.nih.gov/pubmed/37457699 http://dx.doi.org/10.3389/fimmu.2023.1213716 |
work_keys_str_mv | AT huchunmei recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer AT liumin recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer AT liyutao recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer AT zhaoyi recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer AT sharmaamit recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer AT liuhaotian recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer AT schmidtwolfingogh recentadvancesandfutureperspectivesofcartcelltherapyinheadandneckcancer |